Randomized trial comparing terazosin 5 mg daily and doxazosin GITS [gastrointestinal therapeutic system] 4 mg daily in the successful rate of trial without catheter in acute urinary retention with long term follow up.
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2008
At a glance
- Drugs Doxazosin (Primary) ; Terazosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- 15 Dec 2008 Primary outcome amended as reported by ClinicalTrials.gov.
- 13 Dec 2007 New trial record.